Verona Phama Stock Soars to All-Time High as Merck Buys Firm for $10B

finance.yahoo.com/news/verona-phama-stock-soars-time-140452688.html

In This Article:
Key Takeaways
-
Merck is paying about $10 billion for Verona Pharma, expanding its respiratory disease drug portfolio.
-
The acquisition values Verona at $107 per U.S.-listed share, 23% above its closing price yesterday.
-
The purchase gives Merck Verona's Ohtuvayre…

This story appeared on finance.yahoo.com, 2025-07-09 14:04:52.
The Entire Business World on a Single Page. Free to Use →